{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:56:42Z","timestamp":1777960602682,"version":"3.51.4"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T00:00:00Z","timestamp":1339632000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002547","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T21:01:09Z","timestamp":1339707669000},"page":"e1002547","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches"],"prefix":"10.1371","volume":"8","author":[{"given":"Dominik","family":"Wodarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hofacre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia L.","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,6,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/156800907780058844","article-title":"Oncolytic viruses: what's next?","volume":"7","author":"JC Bell","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1535-6108(03)00170-3","article-title":"Getting oncolytic virus therapies off the ground.","volume":"4","author":"JC Bell","year":"2003","journal-title":"Cancer Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/156800907780058862","article-title":"From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.","volume":"7","author":"AM Crompton","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/jgm.800","article-title":"Oncolytic virotherapy for cancer treatment: challenges and solutions.","volume":"7","author":"JJ Davis","year":"2005","journal-title":"J Gene Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/156652305774964677","article-title":"Adenovirus-based cancer gene therapy.","volume":"5","author":"JM Kaplan","year":"2005","journal-title":"Curr Gene Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: genesis to genetic engineering.","volume":"15","author":"E Kelly","year":"2007","journal-title":"Mol Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1357-4310(97)81456-6","article-title":"Replicating viruses as selective cancer therapeutics.","volume":"2","author":"DH Kirn","year":"1996","journal-title":"Mol Med Today"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.4161\/cbt.216","article-title":"Cancer-specific viruses and the development of ONYX-015.","volume":"2","author":"F McCormick","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1038\/sj.onc.1209064","article-title":"Future prospects for oncolytic therapy.","volume":"24","author":"F McCormick","year":"2005","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1038\/sj.onc.1209047","article-title":"Viruses - seeking and destroying the tumor program.","volume":"24","author":"CC O'Shea","year":"2005","journal-title":"Oncogene"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours.","volume":"5","author":"KA Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/14796694.1.2.247","article-title":"Cancer scene investigation: how a cold virus became a tumor killer.","volume":"1","author":"DE Post","year":"2005","journal-title":"Future Oncol"},{"key":"ref13","first-page":"314","article-title":"Naturally oncolytic viruses.","volume":"8","author":"MS Roberts","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","article-title":"Oncolytic viruses in cancer therapy.","volume":"254","author":"MJ Vaha-Koskela","year":"2007","journal-title":"Cancer Lett"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/v2010078","article-title":"Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.","volume":"2","author":"HH Wong","year":"2010","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/rmv.694","article-title":"Non-human viruses developed as therapeutic agent for use in humans.","volume":"21","author":"D Koppers-Lalic","year":"2011","journal-title":"Rev Med Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.1851332","article-title":"Experimental therapy of human glioma by means of a genetically engineered virus mutant.","volume":"252","author":"RL Martuza","year":"1991","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world's first oncolytic virus therapy for cancer treatment.","volume":"98","author":"K Garber","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/cgt.2011.7","article-title":"Clinical development directions in oncolytic viral therapy.","volume":"18","author":"RM Eager","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"ref20","first-page":"3501","article-title":"Viruses as antitumor weapons: defining conditions for tumor remission.","volume":"61","author":"D Wodarz","year":"2001","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/104303403321070847","article-title":"Gene Therapy for Killing p53-Negative Cancer Cells: Use of Replicating Versus Nonreplicating Agents.","volume":"14","author":"D Wodarz","year":"2003","journal-title":"Hum Gene Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jtbi.2008.01.016","article-title":"Modeling of cancer virotherapy with recombinant measles viruses.","volume":"252","author":"Z Bajzer","year":"2008","journal-title":"J Theor Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11538-009-9456-0","article-title":"Optimization of virotherapy for cancer.","volume":"72","author":"M Biesecker","year":"2010","journal-title":"Bull Math Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mbs.2005.11.001","article-title":"Mathematical modeling of cancer radiovirotherapy.","volume":"199","author":"D Dingli","year":"2006","journal-title":"Math Biosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/cgt.2009.40","article-title":"Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.","volume":"16","author":"D Dingli","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-05-2661","article-title":"Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity.","volume":"66","author":"A Friedman","year":"2006","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-1-30","article-title":"Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics.","volume":"1","author":"GP Karev","year":"2006","journal-title":"Biol Direct"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jtbi.2010.01.009","article-title":"ODE models for oncolytic virus dynamics.","volume":"263","author":"NL Komarova","year":"2010","journal-title":"J Theor Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6150-1-6","article-title":"Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.","volume":"1","author":"AS Novozhilov","year":"2006","journal-title":"Biol Direct"},{"key":"ref30","first-page":"1317","article-title":"Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.","volume":"63","author":"LM Wein","year":"2003","journal-title":"Cancer Res"},{"key":"ref31","first-page":"137","article-title":"Computational approaches to study oncolytic virus therapy: insights and challenges.","volume":"8","author":"D Wodarz","year":"2004","journal-title":"Gene Ther Mol Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1098\/rsif.2008.0191","article-title":"Use of oncolytic viruses for the eradication of drug-resistant cancer cells.","volume":"6","author":"D Wodarz","year":"2009","journal-title":"J R Soc Interface"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e4271","DOI":"10.1371\/journal.pone.0004271","article-title":"Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.","volume":"4","author":"D Wodarz","year":"2009","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1001085","DOI":"10.1371\/journal.pcbi.1001085","article-title":"A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.","volume":"7","author":"N Bagheri","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2006.09.029","article-title":"Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus.","volume":"245","author":"R Zurakowski","year":"2007","journal-title":"J Theor Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1078-0432.CCR-08-2082","article-title":"Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.","volume":"15","author":"W Mok","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1158\/0008-5472.CAN-08-2173","article-title":"A multiscale mathematical model for oncolytic virotherapy.","volume":"69","author":"LR Paiva","year":"2009","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1039\/B917597K","article-title":"In silico evolutionary dynamics of tumour virotherapy.","volume":"2","author":"CL Reis","year":"2010","journal-title":"Integr Biol (Camb)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virol.2011.11.014","article-title":"Early infection and spread of a conditionally replicating adenovirus under conditions of plaque formation.","volume":"423","author":"A Hofacre","year":"2012","journal-title":"Virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nbt1037","article-title":"Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp red fluorescent protein.","volume":"22","author":"NC Shaner","year":"2004","journal-title":"Nat Biotechnol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00163881","article-title":"Pathogen invasion and host extinction in lattice structured populations.","volume":"32","author":"K Sato","year":"1994","journal-title":"J Math Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1098\/rspb.1991.0132","article-title":"Mobility Versus Density-Limited Predator Prey Dynamics on Different Spatial Scales.","volume":"246","author":"AM Deroos","year":"1991","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1890\/0012-9658(2001)082[2357:ODASST]2.0.CO;2","article-title":"Oscillatory dynamics and spatial scale: The role of noise and unresolved pattern.","volume":"82","author":"M Pascual","year":"2001","journal-title":"Ecology"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","article-title":"Infectious diseases of humans","author":"RM Anderson","year":"1991"},{"key":"ref45","article-title":"Virus dynamics. Mathematical principles of immunology and virology","author":"MA Nowak","year":"2000"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198540892.001.0001","article-title":"The Spatial and Temporal Dynamics of Host-Parasitoid Interactions","author":"MP Hassell","year":"2000"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1086\/339996","article-title":"Parasite-driven extinction in spatially explicit host-parasite systems.","volume":"159","author":"M Boots","year":"2002","journal-title":"Am Nat"},{"key":"ref48","article-title":"Correlation equations and pair approximations for spatial ecologies.","author":"DA Rand","year":"2009"},{"key":"ref49","first-page":"5073","article-title":"Stochastic Lattice-Gas Model for a Predator-Prey System.","volume":"49","author":"JE Satulovsky","year":"1994","journal-title":"Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1088\/1751-8113\/40\/43\/005","article-title":"Stable oscillations of a predator-prey probabilistic cellular automaton: a mean-field approach.","volume":"40","author":"T Tome","year":"2007","journal-title":"J Phys A Math Gen"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.physrep.2003.08.001","article-title":"Front propagation into unstable states.","volume":"386","author":"W van Saarloos","year":"2003","journal-title":"Phys Rep"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-4371(03)00203-6","article-title":"Interacting particles, the stochastic Fisher-Kolmogorov-Petrovsky-Piscounov equation, and duality.","volume":"325","author":"CR Doering","year":"2003","journal-title":"Physica A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-60327-164-6_17","article-title":"Bacteriophage plaques: theory and analysis.","volume":"501","author":"ST Abedon","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0006-291X(91)91519-I","article-title":"A quantifiable phenotype of viral propagation.","volume":"174","author":"J Yin","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/jtbi.1999.1001","article-title":"Amplification and spread of viruses in a growing plaque.","volume":"200","author":"L You","year":"1999","journal-title":"J Theor Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JVI.62.1.325-330.1988","article-title":"Activation of the human beta interferon gene by the adenovirus type 12 E1B gene.","volume":"62","author":"K Shiroki","year":"1988","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.cdd.4400823","article-title":"Host defense, viruses and apoptosis.","volume":"8","author":"GN Barber","year":"2001","journal-title":"Cell Death Differ"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1128\/JVI.78.16.8641-8653.2004","article-title":"Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway.","volume":"78","author":"C Barreca","year":"2004","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1098\/rsif.2006.0136","article-title":"Modelling dynamics of the type I interferon response to in vitro viral infection.","volume":"3","author":"TJ Howat","year":"2006","journal-title":"J R Soc Interface"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:24:00Z","timestamp":1714044240000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002547"}},"subtitle":[],"editor":[{"given":"Claus O.","family":"Wilke","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,14]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002547","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,14]]}}}